Matinas Biopharma (MTNB) Q2 2024 Earnings

May 9Confirmed
Q1 2023
Q2 2023
Q3 2023
Q2 2024
-0.03
0.3
0.64
0.97

Details

Expected EPS
-0.03
Actual EPS
-0.03
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Matinas Biopharma⁩ (⁦MTNB⁩) has reported earnings of ⁦-0.03⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts